Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

3
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
3
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

2
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
2
Atypical Pneumonia01:14

Atypical Pneumonia

67
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hospital-treated infection associated with Alzheimer's disease pathology: underlying mechanisms.

Molecular psychiatry·2026
Same author

Impact of prenatal LPS on sepsis-related neurobiological outcomes.

Metabolic brain disease·2026
Same author

The effects of neuromodulation through brainwave entrainment on pain in women with fibromyalgia: a randomized controlled clinical trial with Follow-Up.

Pain medicine (Malden, Mass.)·2026
Same author

From Bench to Bedside: Neurofilament Light Chain as a Biomarker in Ischemic Stroke.

Current medical science·2026
Same author

Effects of moderate- and high-intensity exercise on behavior and oxidative damage in male and female rats subjected to early life stress.

Experimental brain research·2026
Same author

From lungs to brain: the neuroimmune impact of respiratory microbiota.

Expert review of respiratory medicine·2026

Related Experiment Video

Updated: Apr 20, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

49.4K

Targets for adjunctive therapy in pneumococcal meningitis.

Tatiana Barichello1, Allan Collodel2, Jaqueline S Generoso2

  • 1Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, Houston, TX, USA; Laboratório de Microbiologia Experimental, Programa de Pós-Graduação em Ciências da Saúde, Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil.

Journal of Neuroimmunology
|December 4, 2014
PubMed
Summary

Pneumococcal meningitis causes severe brain inflammation and lasting neurological damage. This review explores new adjuvant treatments to protect brain function after infection.

Keywords:
MeningitisStreptococcus pneumoniaeTargets of adjunctive therapy

More Related Videos

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

13.2K
Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

13.5K

Related Experiment Videos

Last Updated: Apr 20, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

49.4K
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

13.2K
Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

13.5K

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Immunology

Background:

  • Pneumococcal meningitis is a critical central nervous system (CNS) infection causing significant global mortality.
  • Inflammation triggered by bacterial pathogens crossing the blood-brain barrier leads to neuronal injury.
  • Despite antibiotics, survivors often face severe long-term neurological sequelae.

Purpose of the Study:

  • To review current knowledge on potential targets for adjuvant therapies in acute pneumococcal meningitis.
  • To identify strategies that can mitigate the inflammatory cascade and subsequent neuronal damage.

Main Methods:

  • Literature review of studies on pneumococcal meningitis pathogenesis and treatment.
  • Analysis of inflammatory pathways, including Toll-like receptor signaling and cytokine production.
  • Examination of mechanisms contributing to blood-brain barrier disruption and neuronal injury.

Main Results:

  • The inflammatory cascade involves pathogen recognition, cytokine release, and leukocyte infiltration.
  • Key pathological processes include lipid peroxidation, mitochondrial dysfunction, and increased blood-brain barrier permeability.
  • Existing antibacterial treatments do not fully prevent long-term neurological deficits.

Conclusions:

  • Adjuvant therapies targeting the inflammatory response are crucial for improving outcomes in pneumococcal meningitis.
  • Further research into neuroprotective strategies is needed to reduce long-term sequelae.
  • Identifying specific molecular targets within the inflammatory cascade holds promise for novel therapeutic interventions.